Progress and Perspective in the Treatment of Lung Cancer. Este artículo no está disponible.
Idioma: inglés
Editorial: Springer, 1999
- Tapa dura
- Usado

Librería: S.C. Sumner, Venice, FL, Estados Unidos de AmericaS.C. Sumner
Vendedor de 2 estrellas
Vendedor de IberLibro desde 29 de agosto de 2005
No disponible
Tapa dura
Condición: Usado - Bueno
EUR 36,70
Descripción del artículo del vendedor
No ownership markings; a bit of staining to rear endpapers.
N° de ref. del artículo 004050
- Título
- Progress and Perspective in the Treatment of Lung Cancer
- Autor
- Van Houtte, P. (editor); Klastersky, J. (editor); Rocmans, P. (editor)
- Editorial
- Springer
- Año de publicación
- 1999
- Estado
- Very Good
- Encuadernación
- Hard Cover
- Idioma
- inglés
- ISBN 10
- 3540625488
- ISBN 13
- 9783540625483
Lung cancer is not a single disease process but is a group of biologically variable diseases. Therefore, accurate and complete diagnosis along with complete workup of the patient prior to decision-making in treatment is essential to devise the most appropriate treatment strategy. In North America adenocarcinoma of the lung now accounts for about 40% of all lung cancers and stage for stage these tumors have a poorer prognosis than squamous cell cancers of the lung. Many prognostic indicators have been identified such as genetic markers and neuroen docrine differentiation, which have important roles to play in identifying the patients who would benefit most from active treatment. Screening and early detection have been thought to be sine qua non in early diagnosis of lung cancer. However, a number of controlled trials assessing the value of annual screening for lung cancer have demonstrated in some studies that chest X-rays and/or cytology screening may improve stage distribution, resectability, survival, and fatality but has not shown an impact on disease-specific mortality rates. The Mayo Clinic lung project compar ing quarterly chest X-rays and sputum cytology with routine care in more than 10 000 male smokers indicated that 5-year survival following treatment in the screened patients was better than rates in contemporary clinical practice. However, arguments have been ad vanced as to factors that might have biased the clinical benefits. Other trials are currently under way to deal with this issue along with new molecular markers that may enhance sputum sensitivity.
“Sinopsis” puede pertenecer a otra edición de este título.
De la contraportada
This volume documents the progress that has been made in the treatment of lung cancer, examining in detail the applicability and use of the various therapeutic modalities. Emphasis is placed on the benefits of a multimodality approach to lung cancer, and the editors have sought to achieve a balance between the perspectives offered by US and European authors. The comprehensive coverage of the subject and the expertise of the authors ensure that the volume will be of widest interest.
“Acerca de” puede pertenecer a otra edición de este título.
Resultados de la búsqueda para Progress and Perspective in the Treatment of Lung Cancer
Hay 5 copias más de este libroVer todos los resultados